| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 2,979,100 | 318,823,000 | 22.93% | ||
| 2 | OPHTHOTECH CORP COM | 4,910,487 | 255,640,000 | 18.38% | ||
| 3 | INOGEN INC COM | 3,549,320 | 158,300,000 | 11.38% | ||
| 4 | Wright Medical Group Inc | 4,720,065 | 123,949,000 | 8.91% | PRN | |
| 5 | VANGUARD INTL EQUITY INDEX F | 2,101,000 | 113,412,000 | 8.16% | ||
| 6 | ALDER BIOPHARMACEUTICALS INC | 1,951,183 | 103,354,000 | 7.43% | ||
| 7 | NEVRO CORP | 1,525,704 | 82,007,000 | 5.90% | ||
| 8 | FLEXION THERAPEUTICS INC COM | 2,133,131 | 46,694,000 | 3.36% | ||
| 9 | TOBIRA THERAPEUTICS INC | 2,696,405 | 46,513,000 | 3.35% | ||
| 10 | ADAPTIMMUNE THERAPEUTICS PLC | 1,761,567 | 32,290,000 | 2.32% | ||
| 11 | COLUCID PHARMACEUTICALS INC COM | 3,056,563 | 27,203,000 | 1.96% | ||
| 12 | Otonomy Inc | 875,025 | 20,117,000 | 1.45% | ||
| 13 | TOKAI PHARMACEUTICALS INC | 1,238,252 | 16,469,000 | 1.18% | ||
| 14 | AKEBIA THERAPEUTICS INC | 1,516,387 | 15,604,000 | 1.12% | ||
| 15 | HTG MOLECULAR DIAGNOSTICS IN | 1,280,185 | 14,274,000 | 1.03% | ||
| 16 | INVUITY INC | 740,616 | 10,457,000 | 0.75% | ||
| 17 | GLAUKOS CORP | 75,000 | 2,174,000 | 0.16% | ||
| 18 | AERIE PHARMACEUTICALS INC | 100,000 | 1,765,000 | 0.13% | ||
| 19 | XENON PHARMACEUTICALS INC | 127,563 | 1,471,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-009039, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
